(0.86%) 5 248.49 points
(1.22%) 39 760 points
(0.51%) 16 400 points
(1.25%) $82.37
(1.05%) $1.736
(0.69%) $2 228.00
(-0.19%) $24.71
(0.99%) $918.75
(0.20%) $0.925
(0.57%) $10.83
(-0.02%) $0.791
(0.39%) $92.80
Live Chart Being Loaded With Signals
Jiangsu gdk Biotechnology Co., Ltd., a biological company, engages in the scientific research, production, operation, and service of human vaccines. The company offers quadrivalent influenza virus split and lyophilized human rabies vaccines...
Stats | |
---|---|
Today's Volume | 476 477 |
Average Volume | 935 264 |
Market Cap | 2.27B |
EPS | CNY0 ( 2023-10-27 ) |
Last Dividend | CNY0 ( N/A ) |
Next Dividend | CNY0 ( N/A ) |
P/E | -92.20 |
ATR14 | CNY0.0330 (0.18%) |
Volume Correlation
Jiangsu gdk Biotechnology Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Jiangsu gdk Biotechnology Correlation - Currency/Commodity
Jiangsu gdk Biotechnology Financials
Annual | 2023 |
Revenue: | CNY139.97M |
Gross Profit: | CNY139.97M (100.00 %) |
EPS: | CNY-0.530 |
Q4 | 2023 |
Revenue: | CNY19.12M |
Gross Profit: | CNY19.12M (100.00 %) |
EPS: | CNY-0.440 |
Q3 | 2023 |
Revenue: | CNY-6.30M |
Gross Profit: | CNY-5.15M (81.78 %) |
EPS: | CNY-0.370 |
Q2 | 2023 |
Revenue: | CNY20.92M |
Gross Profit: | CNY15.19M (72.60 %) |
EPS: | CNY-0.0103 |
Financial Reports:
No articles found.
Jiangsu gdk Biotechnology
Jiangsu gdk Biotechnology Co., Ltd., a biological company, engages in the scientific research, production, operation, and service of human vaccines. The company offers quadrivalent influenza virus split and lyophilized human rabies vaccines. Its product pipeline has coverage for the prevention of principal infectious diseases, including influenza, rabies, chickenpox, shingles, and pneumonia. The company was founded in 2008 and is based in Taizhou, China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators